Related references
Note: Only part of the references are listed.Bacterial Overgrowth and Irritable Bowel Syndrome: Unifying Hypothesis or a Spurious Consequence of Proton Pump Inhibitors?
Brennan M. R. Spiegel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Iris Posserud et al.
GUT (2007)
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth
Marek Majewski et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome - A randomized trial
Mark Pimentel et al.
ANNALS OF INTERNAL MEDICINE (2006)
Use and abuse of hydrogen breath tests
M Simrén et al.
GUT (2006)
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence
AI Sharara et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Review article: proton pump inhibitors and bacterial overgrowth
C Williams et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome
A Lupascu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Effect of tegaserod on gut transit in male and female subjects
L Degen et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Detection of bacterial overgrowth in IBS using the lactulose H2 breath test:: Comparison with 14C-D-xylose and healthy controls
B Walters et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth
EC Lauritano et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth
G Nucera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Irritable bowel syndrome: Epidemiology, natural history, health care seeking and emerging risk factors
F Cremonini et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2005)
Small bowel bacterial overgrowth in symptomatic older people: Can it be diagnosed earlier?
DA Elphick et al.
GERONTOLOGY (2005)
The pathogenesis of gastrointestinal bacterial overgrowth
E Husebye
CHEMOTHERAPY (2005)
Treatment of small intestine bacterial overgrowth and related symptoms by rifaximin
M Di Stefano et al.
CHEMOTHERAPY (2005)
Small intestinal bacterial overgrowth - A framework for understanding irritable bowel syndrome
HC Lin
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults
A Parlesak et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Small intestinal bacterial overgrowth and irritable bowel syndrome
G Parisi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2003)
Opioid-induced bowel dysfunction - Pathophysiology and potential new therapies
A Kurz et al.
DRUGS (2003)
AGA technical review on irritable bowel syndrome
DA Drossman et al.
GASTROENTEROLOGY (2002)
American gastroenterological association medical position statement: Irritable bowel syndrome
GASTROENTEROLOGY (2002)
Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms
M Di Stefano et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
The impact of irritable bowel syndrome on health-related quality of life
IM Gralnek et al.
GASTROENTEROLOGY (2000)
Share Paper
